Dietary consumption of Echinacea by mice afflicted with autoimmune (type I) diabetes: Effect of consuming the herb on hemopoietic and immune cell dynamics

Autoimmunity

Volumn 38, Issue 6, 2005, Pages 453-461

  Delorme, Danielle ^a   Miller, Sandra C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Echinacea; Hemopoiesis; NK cells; Type I diabetes

Indexed keywords

ECHINACEA PURPUREA EXTRACT; IMMUNOSTIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL COUNT; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; ECHINACEA; FEEDING; FEMALE; HEMATOPOIETIC CELL; HERB; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; QUANTITATIVE ANALYSIS; SHORT COURSE THERAPY; SPLEEN CELL;

ANIMALS; BONE MARROW CELLS; CELL LINEAGE; DIABETES MELLITUS, TYPE 1; DIET; ECHINACEA; FEMALE; HEMATOPOIESIS; KILLER CELLS, NATURAL; MICE; MICE, INBRED NOD; SPLEEN;

EID: 27944486185     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930500221761     Document Type: Article

References (61)

1. Pierce MA, Chapman HD, Post CM, Svetlanov A, Efrat S, Horwitz M, Serreze DV. Adenovirus early region 3 antiapoptotic 10.4K, 14.5K and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 2003;52:1119-1127.
2. Kojima H, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in liver and reverses diabetes in mice. Nat Med 2003;9:596-603.
3. Honeyman MC, Coulson BS, Stone NJ, et al. Association between rotavirus infection and pancreatic islet autoiromunity in children at risk of developing Type 1 diabetes. Diabetes 2000;49:1319-1323.
4. Yoon J-W, A new look at viruses in type 1 diabetes. Diabetes Metab Rev 1995;11:83-107.
5. Green J, Casabonne D, Newton R. Coxsackie B virus serology and type 1 diabetes mellitus: A systematic review of published case-control studies. Diabetic Med 2004;21(6):507-514.
6. Graves PLM, Norris JM, Palansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM. Limitations of current approaches. Diabetes 1997;46:161-168.
7. Frisk G, Nilsson F, Tuverno T, Friman G, Diderholm H. The possible role of Coxsackie A and echovirus in the pathogenesis of Type 1 diabetes studied by IgM analysis. J Infect Dis 1992;24:13-22.
8. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med 1999;16:509-513.
9. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002;45:1353-1361.
10. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, Bach JF. Early quantitative and functional deficiency of NK1+ - like thymocytes in the NOD mouse. Eur J Immunol 1996;26(12):2989-2998.
11. Baxter AG, Kinder SG, Hammond KJ, Scollay R, Godfrey DI. Association between alphabeta TCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997; 47(4):572-582.
12. Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 1999; 190(7):963-972.
13. Iwakoshi NN, et al. Diabetes prone BB rats are severly deficient in natural killer T cells. Autoimmunity 1999;31:1-14.
14. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shephard D, Naidenko OV, Godfrey DI, Baxter AG. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Intern Immunol 2001;23(7):887-896.
15. Horwitz DA, Gray JD, Ohtsuka K, Hirokawa M, Takahashi T. The immunoregulatory effects of NK cells: The role of TGF-B and implications for autoimmunity. Immunol Today 1997; 18:538-542.
16. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Kaer LV. The natural killer cell ligand a-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001;7(9):1052-1056.
17. Serreze DV, Leiter EH. Insulin-dependent diabetes mellitus in NOD mice and BB rats: Origins in hematopoietic stem cell defects and implications for therapy. In: Shafrir E, editor. Lessons from Animal Diabetes. Smith Gordon Press; London, UK; 1995. p 59-73.
18. Leiter EH. NOD mice and related strains: Research applications in diabetes, AIDS, cancer and other diseases. In: Leiter EH, Atkinson MA, editors. Medical Intelligence Unit. Austin: Landes; 1998. p 208.
19. Berzins SP, Kyparissoudis K, Pellicci DG, Hammond KJ, Sidobre S, Baxter A, Smyth MJ, Kronenberg M, Godfrey DI. Systemic NKT cell deficiency in NO)D mice is not detected in peripheral blood: Implications for human studies. Immunol Cell Biol 2004;82(3):247-252.
20. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Investig 2002;110:793.
21. Cooke A, Phillips JM, Parish NM. Tolerogenic strategies to half or prevent type 1 diabetes. Nat Immunol 2001;9(2): 810-815.
22. Prange S, Zucker P, Jevnikar AM, Singh B. Transplanted MHC class 1-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients. Transplantation 2002;71(7): 982-985.
23. Abu-hadid MM, Lazarovits AI, Madrenas J. Prevention of diabetes mellitus in the non-obese diabetic mouse strain with monoclonal antibodies against the CD45RB molecule. Autoimmunity 2000;33:73-76.
24. Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van stipdonk MJB, Prilliman KR, Schoenberger SP, von Herrath MG. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 2002;16:403-415.
25. Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL. Prevention of diabetes in biobreeding/Worchester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 1986;164: 1145-1159.
26. Maki T, Ichikawa T, Blanco R, Porter J. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 1992;89:3434-3438.
27. Yang ZD, Chen M, Wu R, McDuffie M, Nadler JL. The anti-inflammatory compound lisofylline prevents type 1 diabetes in non-obese diabetic mice. Diabetologie 2002;45:1307-1314.
28. Sharif S, Arreaza GA, Zucker F, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL. Activation of natural killer T cells by a-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 2001;7(9):1057-1062.
29. Hiemastra HS, Schlool NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity. T cell cross reactivity to viral antigen and autoantigens to glutamic acid decarboxylase, Proc Natl Acad Sci USA 2001;98:398-399.
30. Kim KS, Kang Y, Choi SE, Kim JH, Kim HM, Sun B, Jun HS, Yoon JW. Modulation of glucocorticoid-induced GAD expression in pancreatic B-cells by transcriptional activation of the GAD 67 promoter and its possible effect on the development of diabetes. Diabetes 2002;51:2764-2772.
31. Yoon JW, Yoon CS, Lim HW, Huang QQ, Kang Y, Pyun KH, Hirasawa K, Sherwin RS, Jun HS. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 1999;284:1183-1187.
32. Sharma RD, Raghuram. TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type 1 diabetes. Eur J Clin Nutr 1990;44(4):301-306.
33. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Kili Monatsbl Auglenheilkd 1981;178: 383-389.
34. Shanmugrasundaram ERB, Rajeswari G, Baskarin K. Use of Gymnema sylvestre leaf extracts in the control of blood glucose in insulin-dependant diabetes mellitus. J Ethnopharmacol 1990;30:281-294.
35. Bever BO, Sahnd GR. Plants with oral hypoglycemic action. Quart J Crude Drug Res 1979;17:139-196.
36. Chakravarthy BK, Gupa S, Gode KD. Functional beta cell regeneration in rats by epicatechin. Lancet 1981;2:749-760.
37. Suba V, Murugesan T, Arunachalam G, Mandal SC, Saha BP. Anti-diabetic potential of Barleria lupulina extract in rats. Phytomedicine 2004; 11(2-3):202.
38. Madar Z, Abel R, Samish S, Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetes. Eur J Clin Nutr 1988;42:51-54.
39. Marles RJ, Farnsworth N. Antidiabetic plants and their active constituents: An update. Prot J Bot Med 1996;1(3):85-135.
40. Broadhurst CL. Nutrition and non-insulin dependent diabetes mellitus from an anthropological perspective. Alt Med Rev 1997;1(4):378-399.
41. Ernst E. Plants with hypoglycemic activity in humans. Phytomedicine 1997;4(1):73-78.
42. Ma SW, Zhao DL. Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM. Transgeneic plants expressing autoantigens fed to mice to induce immune tolerance. Nat Med 1997;3(7):793-796.
43. Steinmuller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes ML. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhances the resistance of immunosuppressed mice against system infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 1993;15:605-614.
44. Sun LZY, Currier NL, Miller SC. The American coneflower: a prophylactic role involving non-specific immunity. J Altern Comp Med 1999;5:437-446.
45. Currier NL, Miller SC. Echinacea purpurea and melatonin augment natural killer cells in leukemic mice and prolong life span. J Altern Comp Med 2001;7(3):241-251.
46. Currier NL, Miller SC. The effect of immunization with killed tumor cells, with/without feeding of Echinacea purpurea in an erythroleukemic mouse model. J Altern Comp Med 2002; 8(1):49-58.
47. Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. Alphalbeta T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in non-obese diabetic (NOD)/Lt mice by the influence of interleukin IL-4 and/or IL-10. J Exp 1998;187:1047-1056.
48. Mengs U, Clare CB, Poiley JA. Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies. Arzneimittel-Forschung 1991;41:1075-1081.
49. Lersch C, Zenner M, Bauer A, Siemens M, Hart R, Drescher M, Fink U, Dancygier H, Claesson M. Non-specific immunostimulation withy low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (Echinacin) in patients with far advanced colorectal cancers: Reliminary results. Cancer Invest 1992;10:343-348.
50. Melchart D, Linde K, Worku F, Sarkaady L, Horzmann M, Jurcic K, Wagner H. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Altern Comp Med 1995;1:145-160.
51. Miller SC. Age-related differences in the effect of in vivo administration of indomethacin on hemopoietic cell lineages of the spleen and bone marrow of mice. Experientia 1992; 48:674-678.
52. Mahoney MX, Currier NL, Miller SC. Natural killer cell levels in older adult mice are gender-dependent: Thyroxin is a gender-independent natural killer cell stimulant. Nat Immun 1998;16:165-174.
53. Miller SC, Kearney SL. Effect of in vivo administration on the hemopoietic cell populations of the spleen and bone marrow: Profound strain differences between A/J and C57B1/6J mice. Lab An Sci 1997;48(1):74-80.
54. Kasai M, Iwamori M, Nagai Y, Okumura K, Tada I. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 1980;10:175-180.
55. Beck BN, Gillis S, Henney CS. Display of neutral glycolipid ganglio-N-tetrasylceramide (Asialo GM1) on cells of the natureal killer and T linenages. Tansplantation 1982;33: 118-122.
56. Wang B, Geng YB, Wang CR. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001;194(3):313-320.
57. Kitutani H, Makino, S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285-322.
58. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada. M. Analysis of the roles of CD4+ and CD8+T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 1992;22(9): 2387-2393.
59. Yang YB, Min Yoon JW. Direct evidence on the role of NKT cells in the control of T cell-mediated autoimmune diabetes in NOD mice. Diabetes 2000;50:2691.
60. Yui MA, Rothenberg EV. Deranged early T cell development in immunodeficient strains of nonbese diabetic mice. J Immunol 2004;173(9):5381-5391.
61. Godfrey DI, Kinder SJ, Silvera P, Baxter AG. Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabets TCR+CDR-CD8-thymocytes. J Autoimmun 1997;10(3):279-285.